Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE
Clinical trial NCT01539018 · TERMINATED
Trial details
- NCT number
- NCT01539018
- Sponsor
- Egyptian Society of Liver Cancer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.